Close Menu

NEW YORK (GenomeWeb) – Sphere Fluidics announced today that it has closed an additional tranche of $2.9 million in a funding round, securing a total of$4.8 million.

According to Sphere, it will use the funding for working capital for the Cyto-Mine single-cell analysis system, expansion of the UK facility, and to open a new US sales office and demo lab in California, thereby doubling the company's workforce. The Cyto-Mine system automates single-cell screening, sorting, imaging, and dispensing to speed biopharmaceutical discovery.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.